Medi-Tech Insights

[medi-techinsights]

Global Air Ambulance Services Market Size, Share, Trends, Growth Opportunities, Demand, Scope & Challenges by 2027

The sky is not just the limit; it's a lifeline for those in dire need of a rapid and an efficient medical care. The Air Ambulance Services Market Research Report for 2023 provides a comprehensive overview of this dynamic and crucial market, showcasing the latest trends, challenges, and innovations shaping the world of aeromedical transportation. As air ambulance services continue to evolve, it's essential to stay informed about the latest developments, market drivers, and the impact on healthcare access and outcomes.

Growing Role of Air Ambulance Services

The report opens with an exploration of the vital role played by air ambulance services in modern healthcare. It emphasizes the ability of air ambulances to reach remote and underserved areas rapidly and provide life-saving care during critical situations. With statistics highlighting the significance of timely access to advanced medical services, the report establishes the context for the critical work carried out by air ambulance providers.

Market Segmentation: Air Ambulance Services Market

The Air Ambulance Services Market Research Report 2023 meticulously breaks down the industry into various segments, offering a detailed analysis of each. These segments include:

a. Emergency Medical Services (EMS): A deep dive into the world of EMS via air, focusing on the types of emergencies handled, equipment used, and the critical importance of timely response.

b. Commercial Air Ambulances: An examination of the services provided by commercial air ambulance companies, including the medical equipment and staff expertise they offer.

c. Government and Military Air Ambulances: An analysis of the role of government and military aircraft in providing medical evacuation services during emergencies and conflicts.

Key Market Trends: Air Ambulance Services Market

The report highlights the latest trends in the air ambulance services industry. It explores the growing emphasis on telemedicine and the integration of cutting-edge medical technology within air ambulances. Additionally, it discusses the development of eco-friendly, fuel-efficient aircraft for sustainability and the role of data analytics in optimizing patient care during transportation.

Emerging Challenges in the Air Ambulance Services Market

Every industry faces challenges, and the air ambulance services sector is no exception. The report delves into issues such as cost and affordability, regulatory hurdles, and the ethical considerations surrounding pricing and insurance. It also discusses the impact of weather conditions on operations and the need for continuous training and certification of medical personnel.

Key Market Players and Competitive Analysis: Air Ambulance Services Market

Some of the leading players operating in the global air ambulance services market are Acadian Ambulance, Air Methods, American Air Ambulance, Babcock Scandinavian Air Ambulance, Capital Air Ambulance, Express Air Medical Transport, IAS Medical, Ltd., REVA Inc., Lifeguard Ambulance Service LLC., MED FLIGHT, and PHI Air Medical.

Future Growth Projections of Air Ambulance Services Market

The Air Ambulance Services Market Research Report 2023 concludes with a glimpse into the future of the industry. It anticipates further integration of air ambulance services into regional healthcare systems, emphasizing the importance of coordination between ground and air-based healthcare providers. The report also predicts advances in drone technology and their potential applications in emergency medical transport.

Air ambulance services have become a beacon of hope for those facing medical emergencies, regardless of their location. The Air Ambulance Services Market Research Report 2023 serves as a valuable resource for industry professionals, policymakers, and the general public. It sheds light on the challenges and opportunities in this vital field, offering insights that can shape the future of healthcare accessibility and patient outcomes. As the air ambulance services industry continues to soar to new heights, this report helps stakeholders stay informed and adaptable, ensuring that lives continue to be lifted to safety and health, even in the most critical of circumstances.

Get Detailed Insights on Air Ambulance Services Market with TOC & FREE Sample Report @ https://meditechinsights.com/air-ambulance-services-market/

[medi-techinsights]

Global Home Healthcare Services Market Analysis by Size, Share, Emerging Trends & Growth Opportunities by 2027

Home healthcare services are healthcare services provided by both skilled and non-skilled medical professionals in the comfort and convenience of a patient’s home. It includes services such as Post-Acute Care, Palliative Care, Hospice Care, Nursing Care/Wellness Checks, Specialized Care (Alzheimer’s & Dementia Care, Recuperative Care, Stroke Recovery, etc.), Companionship Care, Personal Care and Other Services (Meals and Nutrition Planning, Pharmaceutical Services, 24-hour Monitoring/Live-in Care, Laboratory and Imaging Tests).

Positive Coverage and Growing Investments by Private Equity Firms Fuels the Home Healthcare Services Market Growth

In developed regions, such as USA, Medicare Part A (Hospital Insurance) and/or Medicare Part B (Medical Insurance) covers eligible home health services as long as patients are homebound and require part-time or intermittent skilled services. Generally, a home health care agency coordinates the services as ordered by the doctor or allowed practitioner for the patient. The home health agency caring for the patient must be Medicare-certified.

Some of the covered home health services are: medically necessary part-time or intermittent skilled nursing care, physical therapy, occupational therapy, speech-language pathology services, medical social services, part-time or intermittent home health aide care, injectable osteoporosis drugs for women, durable medical equipment, medical supplies for use at home.

Also, in calendar year (CY) 2023, the Centers for Medicare & Medicaid Services (CMS) predicts that Medicare payments to home health agencies (HHAs) are likely to surge in the aggregate by 0.7% as compared to CY 2022.

Seeing the healthy growth opportunities in the home healthcare services market, many private equity companies have started to invest heavily in the home healthcare services market.

An Increasing Role of Artificial Intelligence (AI) in Home Healthcare Services Market

In recent years, the application of Artificial Intelligence in home healthcare has triggered a move related to how patients and healthcare caregivers’ approach and deliver healthcare services to patients. AI-based sensors track a patient’s health biometrics 24/7. Any irregularities in the readings can instant trigger alerts to the assigned caregiver or agency. AI-based mobile applications helps in offering preventive care by monitoring and managing medical conditions such as obesity, diabetes, cardiac problems, maintaining diet and nutrition records, sending reports, and issuing alerts to concerned caregivers or physicians in case of deviations. AI-based AI voice assistants can help in setting up reminders for taking timely medicines, checking key signs parameters, booking appointments.

“The application of AI in the global home healthcare services market is set to grow rapidly in the upcoming years. Artificial Intelligence has the potential to manage complex care plans, streamline operations of home care agencies by optimizing the scheduling and routing of caregivers, and help in data-driven decision-making.”-Director, Home Healthcare Service Provider, USA

Competitive Landscape Analysis: Home Healthcare Services Market

Some of the leading and emerging players operating in the global home healthcare services market are Amedisys, LHC Group, AccentCare, Elara Caring, Interim HealthCare, VITAS Healthcare, James River Home Health, Home Helpers Home Care, Virginia Kares Home Care Services, Companion Extraordinaire Home Care Services.

Get a FREE Sample Report on Home Healthcare Services Market @ https://meditechinsights.com/home-healthcare-services-market/

[medi-techinsights]

African Pharmaceutical Market is set to witness a significant growth rate by 2027

The pharmaceutical market is a very complex but an emerging market which plays a key role in the growth of the healthcare segment. The pharmaceutical market refers to the market for pharma and medical products, which includes prescription drugs, over-the-counter medications, generic drugs and other healthcare products.

Emerging Growth Opportunities in African Pharmaceutical Market

The pharmaceutical market in Africa is very less developed as compared to the other regions such as North America, Middle-East, Europe, Asia-Pacific, which further makes it a potentially attractive market for new investment opportunities. The African pharmaceutical market is growing rapidly, along with producing many investment and growth opportunities for healthcare companies.

Africa's fast urbanization is further driving the growth for key pharmaceutical companies. With the emergence of metro and tier-1 cities and growing awareness of many health disorders such as diabetes, ADHD, and malaria, there has been a sudden growth in the purchase of terminal disease medications and healthcare costs. Governments are updating their policies to attract foreign investors and leading healthcare companies which is thus leading to an emerging commercial landscape in Africa.

Emerging Shift towards a Western lifestyle in Africa has caused a rapid surge in the non-communicable diseases (NCDs), thus leading for a high demand for chronic prescription drugs. Governments in many African countries are making efforts to enhance their healthcare infrastructures and provide easy access to medicines, which is anticipated to boost the growth of the African pharmaceutical market. Rapid adoption of generic drugs and the growth of e-commerce in the African region are also projected to contribute to the growth of the African pharmaceutical market. 

Positive Market Dynamics and Upcoming Growth Opportunities for Pharma Companies in the African Pharmaceutical Market

Covid-19 Pandemic has shed light on the vulnerability of the healthcare systems and focused on the importance of regions ensuring a basic level of supply security for medical products. Daily drugs and medicines are not easily available in Africa as it depends on imports mostly, with up to 70% of pharmaceutical products being imported from developed regions.

The pharmaceutical market in Africa is divided into three primary categories: prescription drugs, generics drugs, and over-the-counter drugs. Generics have experienced the highest and quickest growth. Production of generics provides a best chance for the private companies to increase their investments and enrich their overall capabilities.

Global healthcare companies need to partner with local enterprises and governments to enhance their chances of success in the pharmaceutical market. Working together on research, public awareness campaigns and medical device provision can help dominate the African pharmaceutical market in their favor.

Upcoming Market Challenges: African Pharmaceutical Market

Africa's pharmaceutical market suffers from many challenges, which includes small and fragmented markets, weak regulatory frameworks, and inadequate manpower capacity. Poor procurement and supply chain systems, as well as policy incoherencies across trade, market, health, and finance market, and lack of funds for R&D activities also affects the growth of the African pharmaceutical market.

Competitive Landscape Analysis: African Pharmaceutical Market

Some of the established players operating in the African pharmaceutical market are Adcock Ingram, F. Hoffmann-La Roche, Pfizer Inc., Novartis AG, Johnson & Johnson (Janssen Global Services LLC), Sanofi, Bayer, Aspen, Cipla, and Merck and Co. Inc..

The African pharmaceutical market is expected to witness a healthy growth in the coming years due to the rapidly growing African population, growing demand for generic drugs, rising cases of chronic diseases and positive government initiatives to enhance easy access to medicines and efficient growth strategies adopted by the key players operating in the African pharmaceutical market.

Get Detailed Insights on African Pharmaceutical Market with a FREE Sample Report @ https://meditechinsights.com/african-pharmaceutical-market/

[medi-techinsights]

GCC Countries Digital Health Market is anticipated to witness a significant growth by 2027 : Increasing Investment Opportunities in KSA & UAE

Digital health refers to the application of digital tools and technologies to monitor and manage illnesses, diseases and health risks and to advertise and promote wellness. The global scope of digital health includes many segments such as Telehealth, mHealth Apps, Connected Medical Devices & Services, Electronic Health Records (EHRs), Electronic Medical Records (EMRs), Healthcare Analytics, Digital Therapeutics, etc.

Rapid Growth in the GCC Countries Digital Health Market Post Covid-19 Pandemic

Due to strict government norms on social distancing during COVID-19 pandemic, GCC countries had seen a fast surge in the application of virtual care solutions, such as online consultations, online prescriptions, online pharmacies, RPM solutions, etc. which is poised to be the upcoming trend in the GCC regions. COVID-19 pandemic has created a fertile environment for all digital health startups. The GCC region had also seen the growth of many health tech startups post Covid-19 pandemic.

“Post Covid-19 Pandemic, to improve patient experience and enhance the quality of care, adoption of digital health has increased in leading GCC markets such as Saudi Arabia and UAE. An increasing number of Saudi-based companies such as Nala Health (Acquired by Integrative Health) and Cura Healthcare which provides instant consultations to tailored digital care programs are the major examples. Also, to reduce the need for physical hospital visits, Saudi Arabia’s Ministry of Health (MoH) has launched many mobile apps such as Mawid, Tabaud, and Seha, which provide virtual consultations.”-Partner, UAE-based Venture Capital Firm

Positive Funding Environment Triggers the Growth of the GCC Countries Digital Health Market

In recent years, the GCC countries has seen a rapid surge in the fundings and investments for digital health startups which is set to boost the growth of the GCC Countries Digital Health Market.

For instance,

In June 2022, WEMA Health, a digital health startup, launched its own services in UAE after raising $3.50 million in a seed funding round led by Dawn Health, Europe’s leading digital health company. The company offers a virtual obesity programme to help its members lose up to 20% of their body weight.

Competitive Landscape Analysis: GCC Countries Digital Health Market

Some of the top and emerging players operating in the GCC Countries digital health market are as follows: -

3M Health Information Systems

GE Healthcare

Philips Healthcare

InterSystems

Cerner Corporation

Epic Systems

Altibbi

Cura Healthcare

Integrative Health (Acquired Nala Health)

Ynmodata

Labayh

AlemHealth

Okadoc

Vezeeta

GluCare.Health

The major factors driving the growth of the GCC Countries digital health market are an increasing funding for healthcare IT and digital transformation in Saudi Arabia and United Arab Emirates, growing awareness of digital-health solutions, adoption of artificial intelligence, IoT and 5G in the healthcare-IT segment, growing healthcare service spending towards non-hospital care. However, potential cybersecurity threats and insufficient legal and regulatory frameworks to counter issues such as data protection, data privacy, and intellectual property rights are set to impact the market’s growth.

Get Detailed Insights on GCC Countries Digital Health Market with a FREE Sample Report @ https://meditechinsights.com/gcc-countries-digital-health-market/

[medi-techinsights]

Global Continuous Renal Replacement Therapy Market is poised to grow at a CAGR of 7 to 9% by 2027

Continuous Renal Replacement Therapy (CRRT) is a slow and gentle form of dialysis which removes excessive fluids and waste products from the blood in a continuous manner, similar to the manner the kidneys functions in healthy people.

Adoption of Continuous Renal Replacement Therapy for the Treatment of Sick Patients with Acute Kidney Injury (AKI) Disorder

AKI is a global disorder and is very common among sick patients. It is projected that approximately 13.3 million people globally are affected by AKI yearly, ~85% of whom live in developing regions. The major objectives of CRRT for sick patients suffering from AKI include maintaining fluid, electrolyte, acid-base, and solute balance, supporting renal recovery, and allowing other supportive interventions to proceed without any further complications.

Major Benefits Associated with CRRT Fuels the Growth of the Continuous Renal Replacement Therapy Market

Hemodynamic instability is common among sick patients with AKI receiving RRT. CRRT may have a better hemodynamic profile as compared to other intermittent therapies, including intermittent hemodialysis (IHD) and sustained low-efficiency dialysis. Among the major benefits offered by CRRT, comparative to other RRT, is the prevention of changes in intracerebral water. CRRT is considered much safer than IHD in patients at risk of cerebral edema.

Increasing Awareness on Kidney Health & Prevention Program Triggers the Growth of the CRRT Market

Presently, a large number of kidney health & prevention programs are run by organizations such as National Kidney Foundation (NKF), The National Kidney Disease Education Program (NKDEP), and local governments across the globe to raise awareness on the evidence-based interventions to enhance understanding, detection, and management of various kidney diseases.

Impact of Covid-19 Pandemic on the Continuous Renal Replacement Therapy Market

Globally, all the healthcare systems have been impacted by the COVID-19 pandemic. During covid-19, approximately 15% to 30% of patients affected with COVID-19 virus admitted to the ICU were showing signs of kidney failure and they required CRRT. In such scenarios, CRRT acted as a life-sustaining and as a life-saving therapy.

Upcoming Market Challenges: Continuous Renal Replacement Therapy Market

The higher costs associated with the CRRT procedures and the risks & complications associated with CRRT such as catheter-related complications, blood loss, infection or access failure, fluctuations in salt balance, hemodialysis-related complications, coagulopathy, and venous thrombosis are likely to impact the growth of the CRRT market in the coming years.

North America Accounts for the Larger Market Share in the CRRT Market

From a geographical outlook, North America accounts for the larger market share in the global continuous renal replacement therapy market. This can be mainly attributed to the growing cases of AKI, rapid innovations in continuous renal replacement therapy products, and a surge in the number of diabetic patients in North America.

Competitive Landscape Analysis: CRRT Market

Some of the leading and promising players operating in the global continuous renal replacement therapy market are Baxter, B. Braun, Fresenius Medical Care AG, Medtronic, Nipro Corporation, etc.

Get Detailed Insights on Continuous Renal Replacement Therapy Market @ https://meditechinsights.com/continuous-renal-replacement-therapy-market/

[medi-techinsights]

Global Obesity Drugs Market valued at $2.3 bn (2022), is Forecasted to Witness a Lucrative CAGR of 25% by 2027

Obesity and overweight are terms which are defined as gain of additional fat thus leading to an increased risk to one's health, which can be measured by using body mass index (BMI) as a baseline. A BMI of over 30 is considered as obese and a BMI of over 25 is considered as overweight. Obesity is a key risk factor contributing to a wide number of diseases such as diabetes, heart disease, and cancer; estimated to over 650 million obese people globally by the World Health Organization (WHO).

Increasing Number of Obese and Overweight Population to Trigger the Demand of Obesity Drugs

Obesity is one of the primary contributors to a major number of non-communicable diseases such as heart disease, stroke and diabetes. World Obesity Atlas 2022, projected the growth of the global obese population to be 16.1% in 2025, almost accounting for 892 million people which will further reach 1,025 million by 2030 with a growth rate of 17.5% in 2030.

Some of the regional obesity burden estimated by World Obesity Atlas 2022 are listed as below: -

1 in each 13 men and 1 in each 5 women are estimated to be obese by 2030 in Africa, equating to approximately 27 million men and 74 million women by 2030. Of the total 101 million obese population, 34 million are estimated to have severe obesity (BMI ≥ 35).

In Americas, by 2030, growth of obesity in men is projected to be 34.41% (1 in each 3 men) as compared to 39.72% in women accounting for 298 million people in the region, out of which 128 million will have severe obesity.

Across the European region, the growth of obesity is expected to be 29.42% in men and 29.97% in women in 2030, with an estimated 102 million men and 113 million women at risk of the complications of obesity.

Competitive Landscape Analysis: Global Obesity Drugs Market

The global obesity drugs market is marked by the presence of well-established and emerging market companies such as follows: -

Novo Nordisk A/S (Denmark)

Eli Lilly and Company (US)

Altimmune (US)

Amgen Inc. (US)

Boehringer Ingelheim (Germany)

Innovent Biologics, Inc. (China)

AstraZeneca plc (UK)

Pfizer Inc. (US)

Irrespective of the arising market challenges such as severe effects associated with weight management medicines such as nausea and diarrhea and shortage of combination therapies, the obesity drugs market has a decent potential to grow at a lucrative rate and is poised to gain a consistent momentum in the upcoming years due to a strong focus on new product development, wide acceptance in developing regions, impact of social media campaigns, and declining pricing trend due to competition, among others.

GET Detailed Insights on Obesity Drugs Market Report @ https://meditechinsights.com/global-obesity-drugs-market/

[medi-techinsights]

Global Sports Medicine Market valued at $7 billion (2022), is anticipated to grow at a CAGR of ~6% by 2027

Sports medicine is a term representing an array of specialties which bridges the academic disciplines of medicine and physical education as well as the basic sciences.

Huge Potential of Sports Medicine in the Treatment of Sports Injuries Fuels the Growth of the Sports Medicine Market

Sporting injuries are unavoidable for any person who regularly engages in sports and physical activities. Recent developments in the regenerative medicine in the sports field focuses on cartilage, tendon, ligament, meniscal and skeletal muscle injuries. The future contains an emerging trend towards prevention through genetics, nutrigenomics and various monitors and wearables in sports medicine which is further poised to drive the growth of the sports medicine market in the forecasted period.

Increasing Emphasis on Developing New and Advanced Sports Medicine Products

There have been many recent advancements and developments in the product category of sports medicine such as rotator cuff repair, high altitude simulation training, anti-gravity treadmill, exoskeletons and hip/knee arthroscopy which are revolutionizing the segment of sports medicine.

An Increasing Number of Sports Injuries Triggers the Demand of Sports Medicine Market 

Currently, more than 3.5 million children under the age of 14 receive their treatments for sports injuries each year. Young athletes and sports person those younger than 8 years are more susceptible to sports injuries than adults. Injuries to the face and head are more common and account for nearly 27% of all sports injuries. Sports injuries in children must be treated at an early stage by using efficient techniques so that children can get back to their daily activities.

Arising Market Challenges: Sports Medicine Market

The hugely increased costs of sports medicine, lack of skilled & professionals, and a worldwide shortage of few raw materials are some of the chief parameters which are likely to affect the growth of the sports medicine market in the upcoming time period.

Geographic Analysis: North America to Hold a Larger Market Share in the Sports Medicine Market

From a geographical analysis, North America is forecasted to hold a higher market share in the sports medicine market. This can be mainly attributed to an increasing cases of sports-related injuries and muscle tears, growing number of absorbable implants, and improved sports healthcare infrastructures.

Competitive Landscape Analysis: Sports Medicine Market

Some of the well-established and top players operating in the global sports medicine market are listed below: -

Arthrex Inc.

DePuy Synthes

Stryker Corporation

CONMED Corporation

GET Detailed Insights on Sports Medicine Market with TOC @ https://meditechinsights.com/sports-medicine-market/

[medi-techinsights]

Global Life Science Tools and Services Market is anticipated to see a CAGR of 8% by 2027

Life science’ is a universal term which studies all the organisms and microorganisms. There are different segments that fall under the life science segment such as cell biology, biotechnology, genetics, molecular biology, biomedicine, and biochemistry. The life science tools and services market is segmented on the basis of technique, products & services and applications.

Technological Developments and Advancements in Life Science Tools and Services Market

Constant and rapid advancements and developments in the life science tools and services market have enabled to develop efficient life science products with significant capabilities and multiple applications, along with cost effectiveness. Such technological developments tend to provide a competitive advantage to all top manufacturers and therefore, all key players are focusing on investing in their research and development activities for new product development and expanding their geographic reach to strengthen their current position in the life science tools and services market. Some of the technological developments are listed below:

In August 2022, Roche launched its Digital LightCycler System, a next-generation digital PCR system to assist clinical researchers in better understanding the nature of a patient’s infection, genetic disease or cancer, leading to early diagnosis.

In June 2022, Waters Corporation introduced New Xevo G3 quadrupole time-of-flight mass spectrometer, a more sensitive spectrometer than its predecessor to drive drug discovery and development.

Positive impact of COVID-19 on the Life Science Tools and Services Market

A significant growth in the COVID-19 cases in 2020 and 2021 had led to a wide adoption of life science tools and technologies. Automation and robotic technologies played a major role in expediting the manual and redundant tasks in pharmaceutical businesses and laboratories as the leading companies across the world were working to prevent the spread of COVID-19. Pharma companies were attempting to develop vaccinations and other medical treatments to counter the COVID-19 pandemic. The top companies had employed multiple market entry techniques, such as growth in the number of biopharmaceutical facilities, partnerships with other top stakeholders and the development of CMOs.

Irrespective of the upcoming challenges such as high costs of life science technologies, unfavorable reimbursement scenarios, and shortage of skilled and experienced technicians, the worldwide life science tools and services market is growing at a decent rate and is poised to gain a consistent momentum in the upcoming years due to a strong focus on new product development, greater acceptance of genomic sequencing, and focus on food and environmental testing, among others.

Competitive Landscape Analysis: Life Science Tools and Services Market

The life science tools and services market is marked by the presence of top and dominating market players such as listed below: -

Agilent Technologies

Thermo Fisher Scientific, Inc.

Becton, Dickinson and Company

F. Hoffmann-La Roche AG

Bio-Rad Laboratories, Inc.

Illumina, Inc.

GET Detailed Insights on Life Science Tools and Services Market @  https://meditechinsights.com/life-science-tools-and-services-market/

[medi-techinsights]

US Branded Generics Market valued at $ 19.1 billion in 2022, is estimated to witness a CAGR of 9-10% by 2027

Branded generics are generic drugs which are given a proprietary market name. It can be developed either by the generic drug company or by the manufacturer and can be marketed only after the patent expiry of the original drug. They are sold by using a brand name instead of a chemical name. An abbreviated new drug application is submitted to the regulatory body for promoting branded generics and it should be therapeutically equivalent to the original drug for which the patent is expired.

Several Advantages Offered by Branded Generics

Due to the several advantages offered by branded generics, their adoption is projected to grow rapidly in USA.

They are sold as alternative to brand-name drugs and are less costly.

For combination drugs, it is tough to remember their generic names. Branded generics can be easily remembered.

Attract several customers who prefer only branded drugs.

They provide quality assurance from top and established companies.

“Branded generics comprise only a small percentage of total generic prescriptions in the US but they are more profitable than unbranded generics.”-Tier I Branded Generic Manufacturer, US

Foray of India Companies Adds A Competitive Intensity to the Growth of the US Branded Generics Market

The share of the Indian companies in the US branded generics market is estimated to grow significantly in the next five years due to the following factors:

High R&D Spend: Leading Indian companies continue to invest heavily in their R&D work. Key Indian players have increased their R&D budgets over the last few years, thus indicating a good launch pipeline of these companies.

Entry of New Indian players: The US market continue to witness the entry of new Indian companies every year, and these companies are expected to further drive the share of Indian players in overall ANDA approvals.

CDMO Entry: Few Indian CDMOs are also planning to enter the US market.

Growth Strategies Adopted by Top Market Players to Establish Their Strong Foothold in the US Branded Generics Market

The major players operating in the US branded generics market have adopted both organic and inorganic growth strategies such as acquisitions, collaborations and partnerships to garner a larger market share.

For instance,

In November 2021, ANI Pharmaceuticals completed the acquisition of Novitium Pharma, significantly enhancing its R&D capabilities and scale of generics and CDMO businesses.

Competitive Landscape Analysis: US Branded Generics Market

The US branded generics market is marked by the presence of established market players such as Teva, Mylan, Sandoz, Sun Pharma, Hikma, among others.

The outlook of the US branded generics market looks promising due to the patent expiry of major drugs, growing number of Indian companies, more profitability as compared to unbranded generics, and unfulfilled patient needs across various therapeutic segments. However, high costs compared to unbranded generics is one of the primary factors which are likely to affect the market growth.

Get Detailed Insights on US Branded Generics Market with TOC @ https://meditechinsights.com/us-branded-generics-market/

[medi-techinsights]

Global Cold Plasma Market is anticipated to witness a lucrative CAGR of 16% by 2026 - Increasing Utilization of Cold Plasma in Wound Healing

Cold plasma, the fourth state of matter is a partially ionized gas comprising ions, electrons, ultraviolet photons, and reactive neutrals such as radicals, excited and ground-state molecules. Plasmas can also be artificially generated through gas dissociation by electricity, microwave radiation, or heat under ambient conditions. Due to the low heat capacity of cold plasma, it finds application in bioengineering, medicine, and therapeutics.

Adoption of Cold Atmospheric Plasma Therapy in Wound Healing-

Cold atmospheric plasma therapy is a new and latest approach in the field of plasma medicine. It consists of a mixture of reactive species that convey antimicrobial activity and affect human tissues. Owing to its environment-friendly and non-invasive nature, this technique has been admired and encouraged to use in different therapeutic regimes like wound healing, tissue regeneration, and skin infection management. Atmospheric pressure cold plasmas could affect different stages of wound healing by helping to activate microorganisms in the first stage and stimulate skin-related cell proliferation and migration in the following period.

Cold Plasma Utilization in Dentistry and Oncology

Cold (non-thermal) plasma treatment can be used to prevent or eliminate infections from bacteria, bacterial biofilms, fungi, and viruses. Prospects of cold plasma in dentistry and oncology look promising due to its anti-microbial properties and its cell death properties on cells. In dentistry, cold plasma showed promising results in tooth bleaching, deactivation of biofilms in teeth, instrument sterilization, and composite restoration. Promising findings obtained from in vivo and in vitro studies of cold plasma in oncology show that it will find its niche in the treatment of cancer patients in the future. However, more studies need to be performed regarding the mechanism of action.

“Growing usage of advanced technologies will drive the market. For instance, the extensive uses of dielectric barrier discharge (DBD) and the non-equilibrium atmospheric pressure plasma jet (N-APPJ) plasma discharge methods have been very effective in various biomedical applications.” - Chief Researcher, Cold Plasma Product Manufacturer, United States

Geographic Overview: Asian Cold Plasma Market Set to Soar

APAC cold plasma market is expected to witness a strong growth in the coming years, due to the adoption of technologically advanced cold plasma products in the healthcare industry, rising demand for decontaminated frozen food, and increasing manufacturing of semiconductor, textile, and polymer industries in this region. The growth in the European region market is attributed to increasing research and development activities, the availability of various FDA-approved products, and the presence of some of the top players in this region.

Competitive Landscape Analysis: Global Cold Plasma Market

Some of the established players operating in the cold plasma market are Apyx Medical Corporation, Nordson Corporation, P2i, and Relyon Plasma GmbH, among others.

Companies Adopt Reliable Growth Strategies to Increase their Market Share in Cold Plasma Market

Players operating in the cold plasma market are adopting organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner a higher market share. For instance,

In October 2021, Plasmacure secured a new series of funding from a consortium with Topfonds Gelderland, NextGen Ventures, European Innovation Council (EIC) Fund, and Credenti B.V. (a group of informal investors) to carry out clinical studies and to sell their product internationally.

Get Detailed Insights on Cold Plasma Market Report with TOC @ https://meditechinsights.com/cold-plasma-market/

[medi-techinsights]

Global Ostomy Devices Market is poised to witness a decent growth of 4-5% to reach $3.2 billion by 2026

An ostomy device is prosthetic medical equipment that gives a means for the collection of waste from a surgically diverted biological system and the formation of a stoma. An ostomy may be necessary due to birth defects, bladder cancer, inflammatory bowel disease, diverticulitis, obesity, and many other medical conditions. It can be categorized into three types colostomy, urostomy, and ileostomy.

Utilization of Ostomy Drainage Bags Drives the Ostomy Devices Market Growth

An ostomy bag is primarily used to collect urine or stool post-surgery, depending on the type of surgery a patient undergoes. Nearly 1 in 500 Americans lives with an ostomy drainage bag. About 30% of people with UC will need ostomy bags at some point in time either temporarily or permanently. In some scenarios, such as the removal of the colon due to colon cancer , the usage of ostomy drainage bags may be permanent. Nowadays, bags and pouches are also very discreet and can be worn under almost any kind of clothing.

“New product launches and innovations in ostomy devices technologies and designs like one-piece ostomy bags, and two-piece ostomy bags, among others will open up a new frontier for the market to grow in the future. Technology has a key role to play.”-President, Product & Innovation Department, Ostomy Device Company, United States

Growing Cases of Colorectal Cancer is driving the Ostomy Devices Market

Globally, colorectal cancer is the third most common type of cancer in men and the second in women with the highest incidence rates in North America, Australia, New Zealand, Europe, and Japan. It is estimated that the number of new patients with colorectal cancer will increase in future. Surgery which is the most common treatment for colorectal cancer results in 10% of the cases in a permanent ostomy which in turn is expected to boost the market growth in the upcoming years.

Market Challenges: Ostomy Devices Market

Although stomas are a relatively common and safe surgery, there are possible complications and risks involved. Complications can develop during the procedure or throughout the recovery. Some of the common complications are skin irritation, bowel obstruction, dehydration, leakage, parastomal hernia (PH), retraction, and ischemia/necrosis.

Regional Overview: Asian Ostomy Devices Market Set To Soar in the Upcoming Years

Asia-Pacific region is expected to witness a strong growth in the upcoming years, due to the rising geriatric population, and an increasing demand for colostomy in countries such as India, and China as a large number of people suffer from bladder issues in this region.

Competitive Landscape Analysis: Ostomy Devices Market

Some of the established and emerging players operating in the global ostomy devices market are Alcare Co. Ltd., Coloplast A/s, ConvaTec Inc., Flexicare Ltd., Welland Medical Limited, 3M, and Hollister Incorporated, among others.

Detailed Insights on Ostomy Devices Market Report with TOC @ https://meditechinsights.com/ostomy-devices-market/

[medi-techinsights]

Global Clear Aligner Market is projected to witness at a significant growth of 23% to reach $8.5 billion by 2026

Clear Aligners also known as invisible aligners are a type of orthodontics device that are used to align and straighten the teeth just like braces. Clear Aligners is a modern and nearly invisible method used for correcting the majority of orthodontic problems such as crooked teeth, gaps, and rotation.

Benefits of Using Clear Aligners over Traditional Metal Braces

Clear aligners are an alternative to traditional braces and are designed to help guide teeth into their proper position. Similar to braces, clear aligners use a gradual force to control tooth movement, but without metal wires or brackets. Orthodontic treatment using clear aligners is faster than traditional braces. Several advantages of using clear aligners over braces include:

Clear aligners are removable so it is easier to brush and floss after meals.

They are easier to keep clean.

They are comfortable and less likely to irritate gums and cheeks.

Technological Advancements in Clear Aligner Therapy Fuels the Clear Aligner Market Growth

Clear aligner therapy has radically changed with the advent of computer-aided technologies. Nowadays, companies use a 3D scan of the dental arches, an impression, or a plaster model. All tooth movement is performed digitally, and the trays are fabricated from a series of 3D-printed models. For instance,

In May 2022, Align Technology announced the launch of its new Cone Beam Computed Tomography (CBCT) integration feature for ClinCheck digital treatment planning software. The CBCT integration feature enables doctors to diagnose and treat a broader range of cases with Invisalign clear aligners.

Growing Cases of Malocclusions Triggers the Demand for Clear Aligners

Malocclusion is a medical disorder where the teeth are misaligned or there is incorrect relation between the teeth of the upper and lower dental arches. The incidence of malocclusion is high with variations between various geographic regions and age groups. It is one of the most common dental problems along with dental caries, gingival disease, and dental fluorosis. Clear aligners are used in orthodontist treatment to fix malocclusion and jaw-related problems.

North America Dominates the Global Clear Aligner Market

From a geographical perspective, North America holds the higher share of the clear aligner market. This can be mainly attributed to the growing R&D investments by leading industry players, higher adoption of technologically advanced products across all age groups, and the presence of leading players in the regions.

Competitive Landscape Analysis: Clear Aligner Market

Some of the established players operating in the global clear aligner market are Align Technology Inc., DynaFlex, Dentsply Sirona Inc., SmileDirectClub, Straumann Group, Danaher, 3M, and Ormco Corporation, among others.

Companies Adopting Growth Strategies to Increase their Market Share in Clear Aligner Market

Top players operating in the global clear aligner market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner higher market share. For instance,

In February 2022, OraPharma announced the launch of its OraFit custom clear aligner system intended for correcting malocclusion.

In February 2022, Ormco Corporation announced the launch of its Spark Clear Aligners Release 12, offering novel clinical enhancements, product optimization, and more flexibility, efficiency, and control.

Get Detailed Research Insights on Clear Aligner Market @ https://meditechinsights.com/global-clear-aligner-market/

[medi-techinsights]

Global Dental Consumables Market is anticipated to grow at a decent rate of 6% to reach $25 billion by 2026

Dental consumables are products used on patients by dental practitioners or dentists to treat and/or perform procedures associated with preventive, restorative, diagnostic, and emergency oral health issues. Dental consumables primarily comprise dental implants, crowns and bridges, dental biomaterial, orthodontics, endodontics, and periodontics.

Advent of CAD/CAM Technology in Cosmetic Dentistry Drives the Dental Consumables Market

Dental CAD/CAM is a relatively new technology that can improve the patient experience during dental treatment. CAD/CAM dentistry uses software that makes it possible for dental professionals to perform complex restorations faster, more efficiently, and sometimes more accurately. Both dental practices and laboratories use CAD/CAM technology to construct restorations like crowns, inlays, onlays, veneers, bridges, dentures, and implant-supported restorations from high-strength ceramic. 

High adoption of dental consumables in the treatment of tooth restoration, dental impairments, and problems related to gingival tissues is expected to further boost the market growth. For Instance,

In December 2021, Dentsply Sirona entered into a partnership with 3Shape, to enhance the technique of capturing dental impressions by integrating 3Shape’s software.

Emerging Growth Opportunities in Dental Tourism Market

Along with the medical tourism industry, dental tourism has become a trending industry as many patients travel around the world to receive dental treatment. The high cost of dental care services, lack of insurance coverage, and dissatisfaction with available services in home countries have motivated people to seek affordable, speedy, and better quality dental care in foreign countries. This market has grown exponentially in the last few years, with countries such as India, Mexico, Hungary, Poland, and Turkey emerging as fast-growing dental tourism destinations.

“The rapid development of digital dentistry technologies over the past several decades has enabled clinicians to improve patient care by significantly reducing the time necessary for the restorative phase of treatment. Advancements in intra-oral scanning and computer-aided design and manufacturing (CAD/CAM) will further boost the market in the coming years.” -President, Dental Consumables Company, United States

Key Market Challenges: Dental Consumables Market

The high costs associated with dental procedures, limited reimbursement policies for dental implants and periodontal surgeries, and high risk and complications associated with dental bridges and orthodontic treatments are some of the key factors restricting the growth of the dental consumables market.

Competitive Landscape Analysis: Dental Consumables Market

Some of the key players operating in the global dental consumables market include Straumann Holding AG, Dentsply Sirona Inc., 3M Company, Zimmer Biomet Holdings Inc., Henry Schein Inc., and Young Innovations Inc., among others.

Customized Research Report on Dental Consumables Market @ https://meditechinsights.com/dental-consumables-market/

[medi-techinsights]

Global Rapid Diagnostic Tests Market is poised to witness a steady CAGR of 4.5% by 2026

Rapid diagnostic tests or RDTs are simple-to-use procedures that provide results in less than 20 minutes. Unlike most standard diagnostic tests, which are required to be sent to a lab for analysis, RDTs are done and results are provided at the point-of-care. Rapid tests are most frequently used to diagnose infectious diseases, such as flu, malaria, HIV, and COVID 19, among others.

Impact of COVID-19 fuels the Rapid Diagnostic Tests Market Demand

The global rapid diagnostic tests market has experienced a significant impact due to the COVID 19 pandemic. Although the demand for RDTs specifically for the detection of SARS-CoV-2 during 2020 and 2021 increased exponentially, the pandemic showed a negative impact on the sales of RDTs for cancer screening, blood glucose, cardiac markers, and other infectious diseases, among others. However, there has been a significant development in the rapid diagnostic tests market during the last two years; some of these are listed below:

In October 2021, the NIH Rapid Acceleration of Diagnostics (RADx) initiative has awarded contracts totaling $77.7 million for the development and manufacturing of 12 new rapid diagnostic tests for SARS-CoV-2; offering high performance and low-cost home and POC tests.

Collaborations and Acquisitions to boost Adoption and Co-develop Advanced Market Solutions

The rapid diagnostic tests market has witnessed a number of acquisitions by market players to either enhance the adoption of these tests or to co-develop advanced diagnostic tests. Some of the strategic initiatives that boost the adoption of RDTs are listed below:

In April 2022, bioMérieux entered into an agreement to acquire Specific Diagnostics, a developer of rapid antimicrobial susceptibility test (AST) system. Rapid AST provides fast and accurate AST results while reducing the global antimicrobial resistance (AMR) burden caused by antibiotic resistant pathogens.

In February 2022, Sorrento Therapeutics, Inc. acquired a majority ownership of Zhengzhou Fortune Bioscience Co., Ltd. (FortuneBio), a diagnostic product manufacturer and Sorrento’s exclusive OEM manufacturer for COVISTIX. With enhanced sensitivity in detecting the Omicron variant, COVISTIX is a rapid antigen detection test for SARS-CoV-2 and its major variants of concern (VOCs).

Competitive Landscape Analysis: Rapid Diagnostic Tests Market

The global rapid diagnostic tests market is marked by the presence of leading industry players such as Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (US), and ACON Laboratories, Inc. (US), and others.

Get Customized Report on Rapid Diagnostic Tests Market @ https://meditechinsights.com/rapid-diagnostic-tests-rdts-market/

[medi-techinsights]

Global Interventional Cardiology Devices Market is projected to witness a decent growth rate of 2 to 3% by 2026

Interventional cardiology is a branch of cardiology that utilizes nonsurgical, catheter-based treatments for structural heart diseases. It utilizes devices such as catheters & sheaths, guidewires, balloons, stents, vascular closure devices, atherectomy devices, intravascular ultrasound (IVUS), and other devices to repair narrowed arteries, damaged or weakened blood vessels, heart valve disorders, and congenital heart diseases.

Rising prevalence of cardiovascular diseases & hypertension, a higher degree of unmet clinical needs, and rising affluence are creating ample opportunities for the interventional cardiology devices market in the APAC region. The growth of the interventional cardiology devices market in the APAC is likely to be driven by China and India.

Technological Innovations Drives the Interventional Cardiology Devices Market Growth

The global interventional cardiology devices market is a technology-driven market and is marked by product innovations. For instance,

In May, 2022, Medtronic received U.S. FDA approval for the Onyx Frontier™ drug-eluting stent (DES). The Onyx Frontier DES is used for the treatment of patients with coronary artery disease (CAD). It offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent.

In April 2022, Translumina launched VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in various international markets including Europe.

Growth Strategies Adopted by Market Players to Establish Their Foothold in Interventional Cardiology Devices Market

The global interventional cardiology devices market is marked by the presence of both established and emerging players. Players operating in this market have adopted both organic and inorganic growth strategies such as acquisitions, and new product launches to garner higher market share. For instance,

In April 2022, Transit Scientific announced the FDA clearance of its XO Cross® Support Catheter Platform to include coronary use. The platform is indicated to guide and support a guidewire during access of the peripheral or coronary vasculature, allow for wire exchanges, and provide a conduit for delivery of saline solutions or diagnostic contrast agents.

The interventional cardiology devices market is expected to grow in the upcoming years due to increasing cardiovascular cases, emerging growth opportunities in the APAC region, technological advancements in interventional cardiology devices, and favourable reimbursement in key markets.

Competitive Landscape Analysis: Interventional Cardiology Devices Market

The market is marked by the presence of key market players such as Medtronic, Boston Scientific, Abbott, Medinol, Biotronik, SMT, Terumo, Lepu Medical, Microport, among others.

Get Customized Report on Interventional Cardiology Devices Market @ https://meditechinsights.com/interventional-cardiology-devices-market/

[medi-techinsights]

Global Animal Health Market is projected to grow at a decent rate of 4% to reach $49 billion by 2026

Animal health is a medical disciple that emphasizes the prevention, detection, control, and therapeutics associated with veterinary diseases, disorders, and injuries. It covers a broad spectrum of animal species, including the domesticated and wild, with an extensive range of conditions that affect several species. It involves taking care of animals with the appropriate use of vaccines, anti-infective and anti-parasitic drugs, pharmaceutical specialty products, performance technologies, and value-added programs, such as livestock data management tools.

Technological Innovations Fuels the Global Animal Health Market

Technological advancements, innovations, and emerging technologies from artificial intelligence to stem cell therapy and new generations of vaccines, have provided greater opportunities to predict, prevent, diagnose and treat animal illness more quickly, accurately, and safely. Veterinary researchers and developers continue to break new ground in reducing disease spread and its impact due to the development of new medicines and vaccinations for animal health.

“A new wave of innovation from smart sensors that continually monitor vital signs and AI-driven prediction technologies to mRNA vaccines, feed supplemented with health-boosting ingredients, and many more scientific advances offer enormous potential for better animal health.” - President, Global Operations, Animal Health Company, United States

Adoption of Pet Animals for Companionship Drives the Animal Health Market

Pet ownership has skyrocketed across the world. Over 50% of households in leading markets currently own a pet which rises to over 80% in nations like Brazil and Argentina. This reflects the increased recognition that pets are not only companions but offer several benefits to our health and happiness. Moreover, pet owners are more likely to get to know their neighborhood than those without pets, which can lead to more community engagement and improves the quality of life and relationships.

Geographic Analysis: Global Animal Health Market

From a geographic perspective, North America holds a larger market share of the animal health market. This can be attributed to a growing number of pet owners in this region - more than 67% of American households own pets, rising incidence of zoonotic diseases, technological advancements & increase in research and development activities by leading players in this region.

Competitive Landscape Analysis: Animal Health Market

Some of the leading players operating in the global animal health market are Merck Animal Health, Ceva Sante Animale, Vetoquinol S.A., Zoetis, Boehringer Ingelheim, Elanco, and IDEXX, among others.

Companies Adopting Growth Strategies to Increase their Market Share in Animal Health Market

Leading players operating in the global animal health market are adopting both organic and inorganic growth strategies such as collaborations, acquisitions, funding, and new product launches to garner higher market share.

For instance, in June 2022, Boehringer Ingelheim and CarthroniX announced that they have entered into a research collaboration to pursue small molecule therapeutics in canine oncology. The collaboration will focus on identifying new molecules to target cancers in dogs.

Get Customized Research Report on Animal Health Market @ https://meditechinsights.com/animal-health-market/

[medi-techinsights]

Global Refurbished Medical Equipment Market is poised to grow at a decent rate of 12% to reach $18 billion by 2026

Refurbishment is defined as a systematic process that ensures the safety and effectiveness of the medical equipment without significantly changing the equipment’s or system’s performance, safety specifications, and/or changing intended use as in its original registration.

Refurbishment of Medical Equipment Contributes to Circular Economy

Refurbished medical equipment serves the purpose of circular economy, by prolonging the life of the equipment, optimal use of resources, and reentering the business ecosystem. It also makes a positive contribution to the environment as it reduces waste generation and saves energy, resources, and raw materials. The DITTA estimates that around 30 MWh can be saved for each ton of refurbished medical imaging equipment.

Cost Containment Strategies Drives the Refurbished Medical Equipment Market Growth

With the use of refurbished medical equipments, the cost to hospitals can be reduced by 20-30 percent while continuing to guarantee safety and high clinical performance. Also, by replacing used, outdated equipment with refurbished medical equipments, the overall quality of healthcare for patients can be improved, which allows for better therapy and treatment and increases the chance of survival.

“The global refurbished medical equipment market played a critical role in helping improve access to affordable quality healthcare during the COVID-19 outbreak. The future prospects of the refurbished medical equipment market look promising due to low production & material cost, and its contribution to the circular economy.” -General Manager, Global Operations and Supply Chain, Medical Device Manufacturer, United States

Market Challenges: Refurbished Medical Equipment Market

The lack of awareness about the benefits associated with the refurbished medical equipments, strong end-user skepticism sentiments regarding the quality & accuracy of this equipments, and stringent regulations on the import and use of refurbished medical equipment in certain countries are some of the key factors that are likely to restrain the growth of refurbished medical equipment market.

Geographic Overview: Refurbished Medical Equipment Market

North America holds the largest market share of the refurbished medical equipment market followed by Europe and the Asia Pacific. Large inventory of old and used medical equipment, hospital budget cuts, and growing prominence of e-commerce platforms that enhance the ease of purchasing refurbished medical devices in this region are some of the key factors driving the growth of this market.

Competitive Landscape Analysis: Refurbished Medical Equipment Market

The refurbished medical equipment market is marked by the presence of established players such as GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Soma Technology, USMed-Equip, and Everx Pvt Ltd., among others.

Customized Report on Refurbished Medical Equipment Market @ https://meditechinsights.com/refurbished-medical-equipment-market/